All News

The type of primary treatment received for prostate cancer-surgery or radiation therapy-is the strongest predictor of lesser-known complications such as the need for additional surgical procedures and development of secondary cancers, according to the authors of a recently published study from the University of Toronto.

The advantages that robotic technologies bring to prostate procedures, partial nephrectomies, and other surgeries that can involve complex reconstruction are not readily apparent in simple extirpative surgeries such as radical nephrectomy. This raises two questions: Are robots being used in radical nephrectomies and if so, why?

Labial and lingual mucosa are useful alternatives to buccal mucosa for graft urethroplasty, according to a recent study.

The second-generation androgen receptor antagonist enzalutamide (XTANDI) significantly improved survival and delayed the time to chemotherapy in men with previously untreated metastatic castrate-resistant prostate cancer, according to a recent study.

While the AUA is pleased with the passing of its urotrauma legislation, the organization has several other legislative goals for 2014.

Promotion of strategies for the repeal of the sustainable growth rate formula and preservation of access to appropriate PSA screening are among the AUA’s top legislative priorities for 2014, the association announced.

A 46-gene diagnostic test accurately predicted, based on biopsy specimens, which men would develop biochemical recurrence (BCR) or metastatic disease following radical prostatectomy, a recently published study found.

In an age where physician fees are primarily determined by the Centers for Medicare & Medicaid Services, insurers who negotiate a percentage of Medicare, or value-based reimbursement programs, it is reasonable to examine the purpose and method of creating and maintaining a master fee schedule, or “charge master.”

Medications that have to be injected or instilled are considered Medicare Part B drugs, and for many offices, these are a money-losing proposition. However, you have a few options that will allow you to provide the needed medications to your patients without loss of revenue.

In this article, I outline my patient discussion concerning prostate cancer screening, which includes defining what the PSA test is, why to screen or not to screen, the screening controversy, current guidelines, and decision aids.

This contribution gives us further evidence of the viability of these alternative graft choices that can be used on a rainy day.

Prostate cancer patients treated with androgen deprivation therapy experienced changes in mental and emotional well-being during treatment, although there was no meaningful decline in emotional quality of life 2 years after treatment, a recent study found.

Large-scale randomized, controlled trials are needed to determine the true risks and benefits of testosterone therapy in older men, the Endocrine Society said.

It certainly makes sense to try to avoid kiddie tax exposure through effective tax planning strategies. The key is to keep your child’s unearned income below or near the $2,000 threshold.

Blogger Henry Rosevear, MD, discusses lessons learned from his first experience in the OR while on his own when things did not go exactly as planned.

The FDA said it is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products.

Researchers from the National Institutes of Health have identified new potential therapeutic targets for muscle-invasive bladder cancer, including important genes and pathways that are disrupted in the disease.

A genomic test capable of predicting the probability of developing metastatic prostate cancer outperformed existing clinical risk factors for predicting biochemical failure and distant metastasis following radiation therapy, researchers reported at the Genitourinary Cancers Symposium in San Francisco.

Separate studies at the Genitourinary Cancers Symposium highlighted the utility of prostate cancer tests Prolaris and ConfirmMDx for Prostate Cancer for treatment planning and identifying aggressive disease, respectively.

The androgen-receptor blocker enzalutamide (XTANDI) increases survival by 29% in men with metastatic castration-resistant prostate cancer (mCRPC) and delays progression of the disease by 81%, according to new phase III study results in men who had not previously received chemotherapy.

When we close the exam room door and sit down to speak with a patient, we are entering into a special covenant protected by law and at the backbone of building patient-provider rapport.

Hector H. Henry, II, MD, MPH, of Concord, NC, who practiced adult and pediatric urology for over 40 years, has died. He was 75.

Drugs and devices in the pipeline from Medivation, Astellas Pharma, Teva Pharmaceuticals, Boston Scientific, Northwest Biotherapeutics, and Generex Biotechnology.

He’s a urologist, but Daniel Shames, MD, has actually had three careers: practicing urologist, FDA official, and pharmaceutical industry consultant.

New products and services from UroGPO, Caldera Medical, Auxilium Pharmaceuticals, VIVUS, and Jeffrey Albaugh, PhD, APRN.

Urologists who are health policy experts say these are 10 things practicing urologists should know.

Mayo Clinic researchers have found amplification of HER2, a known driver of some breast cancers, in micropapillary urothelial carcinoma and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors.

The AUA announced the 2014 Urology Residency Match results last week, reporting that of medical students who submitted preference lists, 64% matched.